Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment

Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment

Rheumatoid arthritis (RA) patients are at high risk of cardiovascular (CV) events, and the chronic inflammatory state may generate quantitative and qualitative changes in lipoprotein fractions. The anti-IL-6 receptor tocilizumab (TCZ), even if effective in inflammation and joint damage prevention, d...

Full description

Bibliographic Details
Main Authors:	Fabio Cacciapaglia, Maria Grazia Anelli, Angela Rinaldi, Marco Fornaro, Giuseppe Lopalco, Crescenzio Scioscia, Giovanni Lapadula, Florenzo Iannone
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2018/2453265

Similar Items

Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients
by: F. Cacciapaglia, et al.
Published: (2016-02-01)

Atherogenic lipid profiles and its management in patients with rheumatoid arthritis
by: Michael T Nurmohamed
Published: (2008-01-01)

Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study
by: Daniela Greco, et al.
Published: (2020-07-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Review of tocilizumab in the treatment of rheumatoid arthritis
by: Yasuaki Okuda
Published: (2008-03-01)

Tocilizumab in the Treatment of Juvenile Rheumatoid Arthritis
by: V.V. Berejniy, et al.
Published: (2015-03-01)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
by: Shetty A, et al.
Published: (2014-03-01)

Use of tocilizumab for rheumatoid arthritis: new evidence
by: Evgeny Lvovich Nasonov
Published: (2011-12-01)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
by: Atsushi Ogata, et al.
Published: (2012-03-01)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
by: Atsushi Ogata, et al.
Published: (2012-01-01)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
by: Pers Yves-Marie, et al.
Published: (2011-11-01)

PREDICTION OF TOCILIZUMAB AND RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS
by: Volkava M. V.
Published: (2019-11-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)

Pharmacoeconomic analysis of subdermal tocilizumab in patients with rheumatoid arthritis
by: S. K. Zyryanov, et al.
Published: (2018-05-01)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
by: Mahamid M, et al.
Published: (2011-10-01)

Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab
by: Yilmaz S, et al.
Published: (2013-10-01)

Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis
by: A. S. Kolbin, et al.
Published: (2020-05-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
by: Han Joo Baek, et al.
Published: (2019-07-01)

Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
by: Irina Anatolyevna Guseva, et al.
Published: (2013-11-01)

Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
by: Graeme Jones, et al.
Published: (2010-01-01)

Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
by: Graeme Jones, et al.
Published: (2010-12-01)

Clinical efficacy of tocilizumab combined with leflunomide in the treatment of rheumatoid arthritis
by: Liang AO, et al.
Published: (2019-09-01)

Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review
by: Al-Shakarchi I, et al.
Published: (2013-07-01)

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
by: Linda L Hushaw, et al.
Published: (2010-03-01)

Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives
by: Giuseppe Lopalco, et al.
Published: (2015-01-01)

Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis
by: Elinoar Hoffman, et al.
Published: (2019-09-01)

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01)

Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
by: Sho Mokuda, et al.
Published: (2013-01-01)

Tocilizumab Was Effective in Repairing the Large Geode in a Patient with Rheumatoid Arthritis
by: Takuya Izumiyama, et al.
Published: (2020-01-01)

Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
by: Mahamid M, et al.
Published: (2011-09-01)

Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
by: Javier Narváez, et al.
Published: (2015-01-01)

Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection
by: Biggioggero M, et al.
Published: (2018-12-01)

EVALUATION OF ULTRASOUND REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-12-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Value of ultrasound indices for the assessment of rheumatoid arthritis activity and tocilizumab therapy efficiency
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-11-01)

FUNCTIONAL ABILITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOCILIZUMAB THERAPY
by: Anna Sergeyevna Starkova, et al.
Published: (2014-02-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Clinical efficacy and safety of tocilizumab in the treatment of seropositive rheumatoid arthritis patients in India
by: Abhishek Kumar, et al.
Published: (2020-01-01)